4//SEC Filing
Ros Matthew 4
Accession 0000899243-22-024929
CIK 0001622229other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 1:51 PM ET
Size
5.8 KB
Accession
0000899243-22-024929
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01$5.87/sh+2,194$12,880→ 2,194 totalExercise: $9.39From: 2022-07-01Exp: 2032-07-01→ Common Stock (2,194 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001673802
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 1:51 PM ET
- Size
- 5.8 KB